Larvol Delta - Aclaris-Therapeutics-Initiates-Phase-1b-ProofofConcept-Trial-in-Patients-with-Asthma-with-its-Novel-Bispecic-AntiTSLPIL4R-Antibody-ATI052

ATI-052 - Aclaris

https://www.globenewswire.com/news-release/2026/02/24/3243334/37216/en/Aclaris-Therapeutics-Initiates-Phase-1b-Proof-of-Concept-Trial-in-Patients-with-Asthma-with-its-Novel-Bispecific-Anti-TSLP-IL-4R%CE%B1-Antibody-ATI-052.html

Feb 24, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next